|
|
Cordis Corporation - Medical Equipment - Deals and Alliances Profile |
| Published Date : 17 February 2010 |
|
|
|
Pages : 39 |
|
| |
|
|
|
|
|
|
|
Cordis Corporation - Medical Equipment - Deals and Alliances Profile
Summary
Cordis Corporation - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Cordis Corporation (Cordis) is a medical device corporation, which is principally engaged in the design and manufacture of breakthrough products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. It functions as a wholly-owned subsidiary of Johnson & Johnson. The company’s product line includes balloons, catheters, guide wires and stents used in cardiology, endovascular and neurovascular therapy.
And More inside the report…
Recent Developments
Sep 29, 2009: Cordis Enters Into Agreement With Boston Scientific
Sep 29, 2009: Cordis Agrees With Boston Scientific To Settle Selected Stent Litigation Cases
Aug 31, 2009: Cordis Reports Enrollment OF First Patient In CYPRESS Trial
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company."
Company Mentioned
The following companies are the major competitors of Cordis Corporation:
Hospira, Inc.
Terumo Corporation
St. Jude Medical, Inc. |
|
|
|
Table of Contents : |
2
List of Tables 3
List of Figures 3
Cordis Corporation, Medical Equipment, Deals By Year, 2004 to YTD 2010 4
Cordis Corporation, Medical Equipment Deals By Type, 2004 to YTD 2010 5
Cordis Corporation, Medical Equipment, Deals By Region, 2004 to YTD 2010 6
Cordis Corporation, Medical Equipment, Deals By Market, 2004 to YTD 2010 7
Cordis Corporation, Medical Equipment, Deals Summary, 2004 to YTD 2010 7
Cordis Corporation, Medical Equipment, Deal Details 8
Partnerships 8
Svelte Medical Systems Enters Into Licensing Agreement With Cordis 8
Cordis Signs An Agreement With Medinol 9
Volcano Signs Agreement With Cordis Endovascular 10
Cordis Signs An Agreement With Brivant 11
Cordis Signs An Agreement With ClearStream Technologies 12
Acquisition 13
Cordis Acquires Ensure Medical 13
Cordis Acquires LuMend 14
Key Competitors 15
Key Employees 15
Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Strategy And Business Planning 16
Dec 03, 2008: Cordis Opens New Facility In Ireland 16
Corporate Communications 16
Oct 13, 2008: Cordis Announces Executive Appointments 16
Jul 10, 2007: Cordis Appoints VP, Microelectronic Technologies 16
Legal and Regulatory 17
Sep 29, 2009: Cordis Agrees With Boston Scientific To Settle Selected Stent Litigation Cases 17
Feb 02, 2009: Cordis Must Pay $22 Million To Spectralytics For Patent Violation 17
Sep 30, 2008: Cordis Wins $1.2 Billion In Stent Case Against Medtronic And Boston Scientific 17
Product News 18
Oct 23, 2009: Cordis Announces Nationwide Recall Of CROSSOVER Sheath Introducer 18
Oct 01, 2009: NEVO Sirolimus-Eluting Coronary Stent Effective For Coronary Artery Disease Than Taxus Liberte Stent 18
Sep 24, 2009: Cordis Presents NEVO RES I Six Months Trial Results Of NEVO Sirolimus-Eluting Coronary Stent At TCT Conference 19
Sep 21, 2009: Cordis Receives FDA Approval For 2.25mm CYPHER Sirolimus-eluting Coronary Stent 20
Aug 31, 2009: Cordis Enrolls First Patient In CYPRESS Trial With CYPHER Sirolimus-Eluting Coronary Stent 20
Aug 31, 2009: Cordis To Complete The Clinical Study For CYPHER ELITE In First Half Of 2015 21
May 21, 2009: Cordis Announces Shelving Work On Its SeptRx PFO 21
May 19, 2009: Cordis’ Nevo Sirolimus-Eluting Coronary Stent Shows Superior Results In Comparison To Taxus Liberte Stent 22
May 12, 2009: Johnson & Johnson (JNJ) To Host A Conference Call For Financial Analysts To Review Trial Results From NEVO RES I 23
Apr 09, 2009: ZEST Clinical Data Shows Better Clinical Outcomes Compare To TAXUS LIBERTE And ENDEAVOR Stents 23
Mar 16, 2009: Cordis Announces NEVO II Clinical Trial Comparing The Nevo Sirolimus-Eluting Coronary Stent To The Xience Stent 24
Oct 28, 2008: Cordis Corporation Completes Patient Enrollment Of RES-ELUTION I Trial 24
Sep 04, 2008: Clinical Data Indicate That Percutaneous Coronary Intervention With The CYPHER Sirolimus-Eluting Coronary Stent Is Comparable To Bypass Surgery In Key Safety Measures In Patients With Diabetes And Multi-Vessel Disease 25
Sep 02, 2008: First Patient Enrolled In Study Evaluating S.M.A.R.T. Nitinol Self-Expandable Stent System In Leg Disease 26
Aug 28, 2008: The Cypher Sirolimus-Eluting Coronary Stent Outperforms The Taxus Stent In People With Diabetes 26
Aug 31, 2007: Cordis Corporation Completes Enrollment Of The ECLIPSE Trial 27
Mar 30, 2007: Cordis Corporation Starts Pivotal Trial for ExoSeal Vascular Closure Device 27
Feb 23, 2007: Cordis Provides Update On SIROCCO Trial Which Shows Minimal Long-Term Restenosis Rates With S.M.A.R.T. Stent 27
Jul 17, 2005: Cordis Compares S.M.A.R.T. CONTROL Nitinol Stent System And Bard Luminexx 6F Vascular Stent 28
Product Approvals 28
Sep 21, 2009: Cordis Receives FDA Approval For 2.25mm CYPHER Sirolimus-eluting Coronary Stent 28
Clinical Trials 29
Oct 01, 2009: NEVO Sirolimus-Eluting Coronary Stent Effective For Coronary Artery Disease Than Taxus Liberte Stent 29
Sep 24, 2009: Cordis Presents NEVO RES I Six Months Trial Results Of NEVO Sirolimus-Eluting Coronary Stent At TCT Conference 29
Aug 31, 2009: Cordis To Complete The Clinical Study For CYPHER ELITE In First Half Of 2015 30
Aug 31, 2009: Cordis Enrolls First Patient In CYPRESS Trial With CYPHER Sirolimus-Eluting Coronary Stent 31
May 19, 2009: Cordis’ Nevo Sirolimus-Eluting Coronary Stent Shows Superior Results In Comparison To Taxus Liberte Stent 32
May 12, 2009: Johnson & Johnson (JNJ) To Host A Conference Call For Financial Analysts To Review Trial Results From NEVO RES I 33
Apr 09, 2009: ZEST Clinical Data Shows Better Clinical Outcomes Compare To TAXUS LIBERTE And ENDEAVOR Stents 33
Mar 16, 2009: Cordis Announces NEVO II Clinical Trial Comparing The Nevo Sirolimus-Eluting Coronary Stent To The Xience Stent 33
Oct 28, 2008: Cordis Corporation Completes Patient Enrollment Of RES-ELUTION I Trial 34
Sep 04, 2008: Clinical Data Indicate That Percutaneous Coronary Intervention With The CYPHER Sirolimus-Eluting Coronary Stent Is Comparable To Bypass Surgery In Key Safety Measures In Patients With Diabetes And Multi-Vessel Disease 35
Sep 02, 2008: First Patient Enrolled In Study Evaluating S.M.A.R.T. Nitinol Self-Expandable Stent System In Leg Disease 36
Aug 28, 2008: The Cypher Sirolimus-Eluting Coronary Stent Outperforms The Taxus Stent In People With Diabetes 36
Aug 31, 2007: Cordis Corporation Completes Enrollment Of The ECLIPSE Trial 36
Mar 30, 2007: Cordis Corporation Starts Pivotal Trial for ExoSeal Vascular Closure Device 37
Feb 23, 2007: Cordis Provides Update On SIROCCO Trial Which Shows Minimal Long-Term Restenosis Rates With S.M.A.R.T. Stent 37
Jul 17, 2005: Cordis Compares S.M.A.R.T. CONTROL Nitinol Stent System And Bard Luminexx 6F Vascular Stent 37
Other Significant Developments 38
Jan 11, 2010: ClearStream Extends Distribution Agreement With Cordis 38
May 23, 2007: Cordis Signs Agreement With Medinol 38
Appendix 39
Methodology 39
About Global Markets Direct 39
Contact Us 39
Disclaimer 39
List of Tables
Cordis Corporation, Medical Equipment, Key Facts 1
Svelte Medical Systems Enters Into Licensing Agreement With Cordis 8
Cordis Signs An Agreement With Medinol 9
Volcano Signs Agreement With Cordis Endovascular 10
Cordis Signs An Agreement With Brivant 11
Cordis Signs An Agreement With ClearStream Technologies 12
Cordis Acquires Ensure Medical 13
Cordis Acquires LuMend 14
List of Figures
Cordis Corporation, Medical Equipment, Deals By Year, 2004 to YTD 2010 4
Cordis Corporation, Medical Equipment, Deals by Type, 2004 to YTD 2010 5
Cordis Corporation, Medical Equipment, Deals By Region, 2004 to YTD 2010 6
Cordis Corporation, Medical Equipment, Deals by Market, 2004 to YTD 2010 7 |
|
|
|
Published By : Global Markets Direct |
|
|
Related
Keywords:
Energy,
Insurance, Financial,
Company Profile,
Industry Profile,
Swot Analysis,
Apparel,
Consumer, Trade,
Information technology,
Food,
Healthcare,
Construction,
Retail,
Design,Oil
and Gas,
Solar,
Miscellaneous,
Business,
Pharmaceuticals,
Technology,
Defense,
Medical,
Travel,
Power,
Metal
|
|
|
|
